The Department of Justice filed an antitrust lawsuit against NewYork-Presbyterian, alleging the hospital used “all-or-nothing” contracts that blocked lower-cost plans and limited competition. The case comes just five weeks after the Justice Department filed a similar lawsuit against OhioHealth. The post DOJ Cracks Down on Unfair Contracts with New Lawsuit Against NewYork-Presbyterian appeared first on…
By MIKE MAGEE For those many, many millions of viewers who tuned in to the live coverage of former President Jimmy Carter’s funeral this week, they were rewarded with two hours of intriguing video images, and moving words and song, including a recounting of the beginnings of environmental advocacy as Los Angeles burns, and John…
The Host Julie Rovner KFF Health News @jrovner Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is the author of the critically praised reference book “Health Care Politics and Policy A to…
When the Agriculture Department posted a recall of chicken nuggets that might be contaminated, it directed consumers to return them or throw the stuff away. When the Consumer Product Safety Commission announced that poorly designed baby loungers could suffocate babies, it warned consumers to immediately stop using them. But when it comes to medical devices,…
It’s that time of year again: In most states, the Affordable Care Act’s annual open enrollment season for health plans begins Nov. 1 and lasts through Jan. 15. Current enrollees who do not update their information or select an alternative will be automatically reenrolled in their current plan or, if that plan is no longer…
Recent developments, including a high-profile acquisition and key regulatory changes, point to a paradigm shift. Cell and gene therapy is becoming increasingly commercially viable, with the potential to improve the lives of millions. The post A New Era for Cell and Gene Therapy Signals New Market Opportunities appeared first on MedCity News.
Zenas Biopharma’s obexelimab achieved a statistically significant and clinically meaningful reduction in signs and symptoms of immunoglobulin G4-related disease, but not to the extent shown by Amgen’s Uplizna in its pivotal study. Still, Zenas points to features of its drug that could make it competitive as a maintenance therapy for the rare autoimmune disorder. The…
[Sponsored] Mayo Clinic physicians developed a clinical decision support tool to standardize care and improve care quality across Mayo Clinic. AskMayoExpert is the evolution of that work. The post The Evolution of a Clinical Decision Support Network appeared first on MedCity News.
On May 22, the House passed a budget reconciliation bill that includes significant changes to the Medicaid program. On June 16, the Senate Finance committee released proposed reconciliation language with some substantive changes to the Medicaid work requirement provisions, but this language may change as the Senate debates the bill. This issue brief provides an…
A universal medical coder, applied consistently across care settings, offers a practical solution to the enduring challenge of data integrity. The post The Case for a Universal Medical Coder in Achieving True Interoperability appeared first on MedCity News.